WO2023144595 - WEB-BASED PHARMACOGENOMICS TOOL
National phase entry is expected:
Publication Number
WO/2023/144595
Publication Date
03.08.2023
International Application No.
PCT/IB2022/051596
International Filing Date
23.02.2022
Title **
[English]
WEB-BASED PHARMACOGENOMICS TOOL
[French]
OUTIL PHARMACOGÉNOMIQUE BASÉ SUR LE WEB
Applicants **
DASMAN DIABETES INSTITUTE
P.O. Box 1180
Dasman, 15462, KW
Inventors
AL MULLA, Fahd
,
JOHN, Sumi Elsa
,
CHANNANATH, Arshad Mohamed
,
Priority Data
17/587,195
28.01.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1245 | |
| EPO | Filing, Examination | 6201 | |
| Japan | Filing | 587 | |
| South Korea | Filing | 574 | |
| USA | Filing, Examination | 2710 |
Total: 11317 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
A system and method of providing personalized medication dosing recommendations are provided. The web-based pharmacogenomics tool includes a system and method for analyzing a patient's genomic information and producing a personalized report containing recommendations to adjust medication selection and dosing for the patient based upon known pharmacogenomic interactions. The tool is adapted to receive a whole genome screening file from a user, use Stargazer to detect diplotypes in specific pharmacogenes; assigning allele functionality, phenotype, drug names, and recommended dosage information based upon the detected diplotypes, and generating a personalized pharmacogenomics report including recommendations of medications to use or avoid and/or suggested dosing adjustments. The tool allows users to submit genomic information in either hg48 or hg19 format.[French]
L'invention concerne un système et un procédé de fourniture de recommandations de dosage de médicament personnalisées. L'outil pharmacogénomique basé sur le Web comprend un système et un procédé pour analyser des informations génomiques d'un patient et produire un rapport personnalisé contenant des recommandations pour ajuster la sélection et le dosage de médicaments pour le patient sur la base d'interactions pharmacogénomiques connues. L'outil est conçu pour recevoir un fichier de criblage de génome entier d'un utilisateur, utiliser Stargazer pour détecter des diplotypes dans des pharmacogènes spécifiques ; attribuer une fonctionnalité d'allèle, un phénotype, des noms de médicament et des informations de dosage recommandées sur la base des diplotypes détectés, et générer un rapport pharmacogénomique personnalisé comprenant des recommandations de médicaments à utiliser ou éviter et/ou suggérer des ajustements de dosage. L'outil permet aux utilisateurs de soumettre des informations génomiques dans un format hg48 ou hg19.